Search Results

There are 2929 results for: content related to: The JAK2 V617F mutation and thrombosis

  1. You have free access to this content
    JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 517–523, Alberto Alvarez-Larrán, Beatriz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández-Boluda, Luz Martínez-Avilés, Concepción Fernández-Rodríguez, Montse Gómez, Luis Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado and Carlos Besses

    Version of Record online : 21 FEB 2014, DOI: 10.1002/ajh.23676

  2. You have free access to this content
    The role of serum erythropoietin level and jak2 v617f allele burden in the diagnosis of polycythaemia vera

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 411–417, Àgueda Ancochea, Alberto Álvarez-Larrán, Cristian Morales-Indiano, Francesc García-Pallarols, Luz Martínez-Avilés, Anna Angona, Alicia Senín, Beatriz Bellosillo and Carles Besses

    Version of Record online : 18 JUL 2014, DOI: 10.1111/bjh.13047

  3. You have free access to this content
    JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

    British Journal of Haematology

    Volume 150, Issue 3, August 2010, Pages: 334–344, Seido Oku, Katsuto Takenaka, Takuro Kuriyama, Kotaro Shide, Takashi Kumano, Yoshikane Kikushige, Shingo Urata, Takuji Yamauchi, Chika Iwamoto, Haruko K. Shimoda, Toshihiro Miyamoto, Koji Nagafuji, Junji Kishimoto, Kazuya Shimoda and Koichi Akashi

    Version of Record online : 10 JUN 2010, DOI: 10.1111/j.1365-2141.2010.08249.x

  4. Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera

    European Journal of Haematology

    Volume 94, Issue 3, March 2015, Pages: 251–257, Anna Angona, Alberto Alvarez-Larrán, Beatriz Bellosillo, Luz Martínez-Avilés, Laura Camacho, Concepción Fernández-Rodríguez, Silvia Pairet, Raquel Longarón, Águeda Ancochea, Alicia Senín, Lourdes Florensa and Carles Besses

    Version of Record online : 13 SEP 2014, DOI: 10.1111/ejh.12425

  5. You have free access to this content
    Experimental therapeutics for patients with myeloproliferative neoplasias

    Cancer

    Volume 117, Issue 4, 15 February 2011, Pages: 662–676, Meetu Agrawal, Ravin J. Garg, Jorge Cortes, Hagop Kantarjian, Srdan Verstovsek and Alfonso Quintas-Cardama

    Version of Record online : 4 OCT 2010, DOI: 10.1002/cncr.25672

  6. You have full text access to this Open Access content
    Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 2, February 2009, Pages: 215–237, Ayalew Tefferi

    Version of Record online : 23 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00559.x

  7. You have free access to this content
    Molecular diagnostics of myeloproliferative neoplasms

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 270–279, Stephen E. Langabeer, Hajnalka Andrikovics, Julia Asp, Beatriz Bellosillo, Serge Carillo, Karl Haslam, Lasse Kjaer, Eric Lippert, Olivier Mansier, Elisabeth Oppliger Leibundgut, Melanie J. Percy, Naomi Porret, Lars Palmqvist, Jiri Schwarz, Mary F. McMullin, Susanne Schnittger, Niels Pallisgaard, Sylvie Hermouet and on behalf of the MPN&MPNr-EuroNet

    Version of Record online : 18 MAY 2015, DOI: 10.1111/ejh.12578

  8. You have free access to this content
    Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

    Cancer

    Volume 109, Issue 11, 1 June 2007, Pages: 2279–2284, Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy M. Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin-Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani and Ayalew Tefferi

    Version of Record online : 17 APR 2007, DOI: 10.1002/cncr.22663

  9. You have free access to this content
    Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 25–34, Anthony J. Bench, Helen E. White, Letizia Foroni, Anna L. Godfrey, Gareth Gerrard, Susanna Akiki, Abida Awan, Ian Carter, Andrea Goday-Fernandez, Stephen E. Langabeer, Tim Clench, Jordan Clark, Paul A. Evans, David Grimwade, Anna Schuh, Mary F. McMullin, Anthony R. Green, Claire N. Harrison and Nicholas C. P. Cross

    Version of Record online : 11 OCT 2012, DOI: 10.1111/bjh.12075

  10. You have free access to this content
    The JAK2 V617F mutation in patients with cerebral venous thrombosis

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 6, June 2012, Pages: 998–1003, S. M. PASSAMONTI, E. BIGUZZI, M. CAZZOLA, F. FRANCHI, F. GIANNIELLO, P. BUCCIARELLI, D. PIETRA, P. M. MANNUCCI and I. MARTINELLI

    Version of Record online : 31 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04719.x

  11. You have free access to this content
    Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms

    British Journal of Haematology

    Volume 147, Issue 4, November 2009, Pages: 495–506, Lizz F. Grimwade, Lisa Happerfield, Colin Tristram, Gary McIntosh, Mark Rees, Anthony J. Bench, Elaine M. Boyd, Marie Hall, Amy Quinn, Nigel Piggott, Paul Scorer, Mike A. Scott and Wendy N. Erber

    Version of Record online : 31 AUG 2009, DOI: 10.1111/j.1365-2141.2009.07870.x

  12. JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

    International Journal of Laboratory Hematology

    Volume 37, Issue 5, October 2015, Pages: 654–660, L. C. Macedo, B. C. Santos, S. Pagliarini-e-Silva, K. B. B. Pagnano, C. Rodrigues, F. C. Quintero, M. E. Ferreira, E. C. Baraldi, E. P. Ambrosio-Albuquerque, A. M. Sell and J. E. L. Visentainer

    Version of Record online : 11 MAY 2015, DOI: 10.1111/ijlh.12380

  13. You have free access to this content
    Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 70–79, Camilla Nielsen, Henrik S. Birgens, Børge G. Nordestgaard and Stig E. Bojesen

    Version of Record online : 1 NOV 2012, DOI: 10.1111/bjh.12099

  14. You have free access to this content
    Splanchnic vein thrombosis in myeloproliferative neoplasms

    British Journal of Haematology

    Volume 162, Issue 6, September 2013, Pages: 730–747, Mallika Sekhar, Kathryn McVinnie and Andrew K. Burroughs

    Version of Record online : 15 JUL 2013, DOI: 10.1111/bjh.12461

  15. Somatic Mutations in Polycythaemia Vera and Other Philadelphia Chromosome Negative Myeloproliferative Neoplasms

    Standard Article

    eLS

    Lukasz P Gondek and Jerry L Spivak

    Published Online : 17 DEC 2012, DOI: 10.1002/9780470015902.a0024249

  16. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms – a multicentric study on 529 patients

    British Journal of Haematology

    Adrian P. Trifa, Claudia Bănescu, Mihaela Tevet, Anca Bojan, Delia Dima, Laura Urian, Tünde Török-Vistai, Viola M. Popov, Mihnea Zdrenghea, Ljubomir Petrov, Anca Vasilache, Meilin Murat, Daniela Georgescu, Mihaela Popescu, Oana Pătrinoiu, Marius Balea, Roxana Costache, Elena Coleș, Carmen Șaguna, Nicoleta Berbec, Ana-Maria Vlădăreanu, Romeo G. Mihăilă, Horia Bumbea, Andrei Cucuianu and Radu A. Popp

    Version of Record online : 7 APR 2016, DOI: 10.1111/bjh.14041

  17. You have free access to this content
    The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

    British Journal of Haematology

    Volume 131, Issue 3, November 2005, Pages: 320–328, Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin-Yang Li, Martha Wadleigh and D. Gary Gilliland

    Version of Record online : 26 SEP 2005, DOI: 10.1111/j.1365-2141.2005.05776.x

  18. Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia

    Pediatric Blood & Cancer

    Volume 51, Issue 6, December 2008, Pages: 802–805, Takuya Nakatani, Toshihiko Imamura, Hiroyuki Ishida, Katsuji Wakaizumi, Tohru Yamamoto, Osamu Otabe, Tsuyoshi Ishigami, Souichi Adachi and Akira Morimoto

    Version of Record online : 18 SEP 2008, DOI: 10.1002/pbc.21730

  19. JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status

    European Journal of Haematology

    Volume 77, Issue 3, September 2006, Pages: 210–216, Paula G. Heller, Paola R. Lev, Juan P. Salim, Laura I. Kornblihtt, Nora P. Goette, Carlos D. Chazarreta, Ana C. Glembotsky, Patricia S. Vassallu, Rosana F. Marta and Felisa C. Molinas

    Version of Record online : 17 MAY 2006, DOI: 10.1111/j.1600-0609.2006.00688.x

  20. You have free access to this content
    JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets

    British Journal of Haematology

    Volume 139, Issue 1, October 2007, Pages: 64–69, Kohtaro Toyama, Masamitsu Karasawa, Arito Yamane, Hiroyuki Irisawa, Akihiko Yokohama, Takayuki Saitoh, Hiroshi Handa, Takafumi Matsushima, Morio Sawamura, Shuichi Miyawaki, Hirokazu Murakami, Yoshihisa Nojima and Norifumi Tsukamoto

    Version of Record online : 11 SEP 2007, DOI: 10.1111/j.1365-2141.2007.06755.x